Renal effects of neuropeptide Y

Pflugers Archiv European Journal of Physiology

Volumn 435, Issue 4, 1998, Pages 443-453

  Bischoff, Angela ^a   Michel, Martin C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BRADYKININ; BRADYKININ ANTAGONIST; CALMIDAZOLIUM; CALMODULIN INHIBITOR; CAPTOPRIL; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GALLOPAMIL; ICATIBANT; INDOMETACIN; LOSARTAN; METHOXAMINE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NIFEDIPINE; NITROPRUSSIDE SODIUM; PEPTIDE YY; PHENTOLAMINE; PRAZOSIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RAMIPRILAT; RECEPTOR SUBTYPE; RESERPINE; TACROLIMUS; UNINDEXED DRUG; VASOPRESSIN;

DIURESIS; DOG; ELECTROLYTE EXCRETION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MONKEY; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; RENIN RELEASE; REVIEW;

ANIMALS; HUMANS; KIDNEY; NEUROPEPTIDE Y; RENAL CIRCULATION; WATER-ELECTROLYTE BALANCE;

EID: 0031884714     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004240050538     Document Type: Review

References (112)

1. Abbott CA, Baker E, Sutherland GR, McCaughan GW (1994) Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics 40: 331-338
2. Ahlborg G, Lundberg JM (1994) Inhibitory effects of neuropeptide Y on splanchnic glycogenolysis and renin release in humans. Clin Physiol 14: 187-196
3. Akpogomeh BA, Johns EJ (1990) The a-adrenoceptor mediating the tubular actions of the renal nerves in spontaneously hypertensive and stroke-prone spontaneously hypertensive rats. J Auton Pharmacol 10: 201-212
4. Allen JM, Godfrey NP, Yeats JC, Bing RF, Bloom SR (1986) Neuropeptide Y in renovascular models of hypertension in the rat. Clin Sci 70: 485-488
5. Allen JM, Raine AEG, Ledingham JGG, Bloom SR (1985) Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci 68: 373-377
6. Allen JM, Hanson C, Lee Y, Mattin R, Unwin RJ (1986) Renal effects of the homologous neuropeptides pancreatic polypeptide (PP) and neuropeptide Y (NPY) in conscious rabbits (abstract). J Physiol (Lond) 376: 24P
7. Aubert JF, Burnier M, Waeber B, Nussberger J, Dipette DJ, Burris JF, Brunner HR (1988) Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels. J Pharmacol Exp Ther 244: 1109-1115
8. Aubert JF, Walker P, Grouzmann E, Nussberger J, Brunner HR, Waeber B (1992) Inhibitory effect of neuropeptide Y on stimulated renin secretion in awake rats. Clin Exp Pharmacol Physiol 19: 223-228
9. Ballesta J, Polak JM, Allen JM, Bloom SR (1984) The nerves of the juxtaglomerula apparatus of man and other mammals contain the potent peptide NPY. Histochemistry 80: 483-485
10. Ballesta J, Lawson JA, Pals DT, Ludens JH, Lee YC, Bloom SR, Polak JM (1987) Significant depletion of NPY in the innervation of the rat mesenteric, renal arteries and kidneys in experimentally (aorta coarctation) induced hypertension. Histochemistry 87: 273-278
11. Baranowska B, Gutkowska J, Lemire A, Cantin M, Genest J (1987) Opposite effects of neuropeptide Y (NPY) and polypeptide YY (PYY) on plasma immunoreactive atrial natriuretic factor (IR-ANF) in rats. Biochem Biophys Res Commun 145: 680-685
12. Bard JA, Walker MW, Branchek TA, Weinshank RL (1995) Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 270: 26762-26765
13. Bischoff A, Michel MC (1996) Opposite modulation of tubular neuropeptide Y effects by the bradykinin antagonist, HOE 140, and the converting enzyme inhibitor, ramiprilat, in rat kidney (abstract). Naunyn-Schmiedeberg's Arch Pharmacol 353 (Suppl) R50
14. Bischoff A, Erdbrügger W, Michel MC (1994) Indomethacin abolishes diuretic and natriuretic effects of NPY but not reductions in renal blood flow (abstract). FASEB J 8: A585
15. Bischoff A, Kötting A, Erdbrügger W, Schimiczek M, Grandt D, Michel MC (1995) Radioligand binding detects NPY receptors in rabbit and guinea pig but not in rat or human kidney (abstract). Naunyn-Schmiedeberg's Arch Pharmacol 352 (Suppl) R25
16. Bischoff A, Stickan-Verfürth M, Michel MC (1995) Interaction between neuropeptide Y and nifedipine in the regulation of rat renal function (abstract). Br J Pharmacol 116 (Suppl) 153P
17. Bischoff A, Erdbrügger W, Smits J, Michel MC (1996) Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent from renal blood flow reduction. J Physiol 495: 525-534
18. 5 are involved in the renal effects of neuropeptide Y. Br J Pharmacol 120: 1335-1343
19. 1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y. Naunyn-Schmiedeberg's Arch Pharmacol 356: 635-640
20. Bischoff A, Gerbracht A, Michel MC (1997) Differential alteration of systemic vascular, renal vascular and tubular NPY responsiveness in spontaneously hypertensive rats (abstract). Naunyn-Schmiedeberg's Arch Pharmacol 355 (Suppl) R109
21. Bischoff A, Stickan-Verfürth M, Michel MC (1997) Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats. Pflügers Arch 434: 57-62
22. Blasingham MC, Nasjletti A (1979) Contribution of renal prostaglandins to the natriuretic action of bradykinin in the dog. Am J Physiol 237: F182-F187
23. Carretero OA, Scicli AG (1980) The renal kallikrein-kinin system. Am J Physiol 238: F247-F255
24. Chen C, Lokhandwala MF (1995) Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats. Naunyn-Schmiedeberg's Arch Pharmacol 352: 194-200
25. Chen H, Bischoff A, Schäfers RF, Wambach G, Philipp T, Michel MC (1997) Vasoconstriction of rat renal interlobar arteries by noradrenaline and neuropeptide Y. J Auton Pharmacol 17: 137-146
26. Chen X, Knuepfer MM, Westfall TC (1990) Hemodynamic and sympathetic effects of spinal administration of neuropeptide Y in rats. Am J Physiol 259: H1674-H1680
27. Chevendra V, Weaver LC (1992) Distributions of neuropeptide Y, vasoactive intestinal peptide and somatostatin in populations of postganglionic neurons innervating the rat kidney, spleen and intestine. Neuroscience 50: 727-743
28. Corder R, Vallotton MB, Lowry PJ, Ramage AG (1989) Neuropeptide Y lowers plasma renin activity in the anaesthetised cat. Neuropeptides 14: 111-114
29. Dietrich MS, Fretschner M, Nobiling R, Persson PB, Steinhausen M (1991) Renovascular effects of neuropeptide-Y in the split hydronephrotic rat kidney: non-uniform pattern of vascular reactivity. J Physiol (Lond) 444: 303-315
30. Dillingham MA, Anderson RJ (1989) Mechanism of neuropeptide Y inhibition of vasopressin action in rat cortical collecting tubule. Am J Physiol 256: F408-F413
31. Doods HN, Wienen W, Entzeroth M, Rudolf K, Eberlein W, Engel W, Wieland HA (1995) Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226. J Pharmacol Exp Ther 275: 136-142
32. Doods HN, Wieland HA, Engel W, Eberlein W, Willim K-D, Entzeroth M, Wienen W, Rudolf K (1996) BIBP 3226, the first selective NPY Y1 receptor antagonist: a review of its pharmacological properties. Regul Pept 65: 71-77
33. Echtenkamp SF, Dandrige PF (1989) Renal actions of neuropeptide Y in the primate. Am J Physiol (Lond) 256: F524-F531
34. Edvinsson L, Hakanson R, Wahlestedt C, Uddman R (1987) Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol Sci 8: 231-235
35. Edwards RM (1990) Neuropeptide Y inhibits cAMP accumulation in renal proximal convoluted tubules. Regul Pept 30: 201-206
36. ++ and calmodulin. J Pharmacol Exp Ther 246: 479-484
37. Evequoz D, Aubert J-F, Nussberger J, Biollaz J, Diezi J, Brunner HR, Waeber B (1996) Effects of neuropeptide Y on intrarenal hemodynamics, plasma renin activity and urinary sodium excretion in rats. Nephron 73: 467-472
38. Feng QP, Hedner T, Andersson B, Lundberg JM, Waagstein F (1994) Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Br Heart J 71: 261-267
39. Firth JD, Raine AEG, Ledingham JGG (1990) The mechanism of pressure natriuresis. J Hypertension 8: 97-103
40. Gehlert DR, Beavers LS, Johnson D, Gackenheimer SL, Schober DA, Gadski RA (1996) Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol Pharmacol 49: 224-228
41. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382: 168-171
42. 5-NPY receptor responsiveness is different in male and female rats (abstract). Naunyn-Schmiedeberg's Arch Pharmacol 355 (Suppl) R109
43. Gimpl G, Wahl J, Lang RE (1991) Identification of a receptor protein for neuropeptide Y in rabbit kidney. G-protein association and inhibition of adenylate cyclase. FEBS Lett 279: 219-222
44. Grandt D, Teyssen S, Schimiczek M, Reeve JR Jr, Feth F, Rascher W, Hirche H, Singer MV, Layer P, Goebell H, Ho FJ, Eysselein VE (1992) Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochem Biophys Res Commun 186: 1299-1306
45. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR Jr (1994) Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51: 151-159
46. Grandt D, Schimiczek M, Rascher W, Feth F, Shively J, Lee TD, Davis MT, Reeve JR Jr, Michel MC (1996) Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regul Pept 67: 33-37
47. Granger JP, Hall JE (1985) Acute and chronic actions of bradykinin on renal function and arterial pressure. Am J Physiol 248: F87-E92
48. Gregor P, Feng Y, DeCarr LB, Cornfield LJ, McCaleb ML (1996) Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J Biol Chem 271: 27776-27781
49. Gregor P, Millham ML, Feng Y, DeCarr LB, McCaleb ML, Cornfield LJ (1996) Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor family. FEBS Lett 381: 58-62
50. Grenier FC, Rollins TE, Smith WL (1981) Kinin-induced prostaglandin synthesis by renal papillary collecting tubule cells in culture. Am J Physiol 241: F94-F104
51. Grouzmann E, Alvarez-Bolado G, Meyer C, Osterheld MC, Burnier M, Brunner HR, Waeber B (1994) Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue. Peptides 15: 1377-1382
52. Hackenthal E, Aktories K, Jakobs KH, Lang RE (1987) Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. Am J Physiol 252: F543-F550
53. 1 receptor antagonist. J Pharmacol Exp Ther 275: 1261-1266
54. Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J, Velazquez N, McCaleb ML (1996) Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 271: 26315-26319
55. 1 receptor subclass. J Med Chem 38: 4579-4586
56. Knight DS, Fabre RD, Beal JA (1989) Identification of noradrenergic nerve terminals immunoreactive for neuropeptide Y and vasoactive intestinal peptide in rat kidney. Am J Anatomy 184: 190-204
57. Larhammar D (1996) Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 62: 1-11
58. Leys K, Schachter M, Sever P (1987) Autoradiographic localisation of NPY receptors in rabbit kidney: comparison with rat, guinea-pig and human. Eur J Pharmacol 134: 233-237
59. 2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Physiol 262: R72-R76
60. 1 receptor antagonist BIBP 3226. Br J Pharmacol 116: 2971-2982
61. Lundberg JM, Torssell L, Sollevi A, Pernow J, Theodorsson-Norheim E, Anggard A, Hamberger B (1985) Neuropeptide Y and sympathetic vascular control in man. Regul Pept 13: 41-52
62. Lundell I, Blomquist AG, Berglund MM, Schober DA, Johnson D, Statnick MA, Gadski RA, Gehlert DR, Larhammar D (1995) Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 270: 29123-29128
63. Lundell I, Statnick MA, Johnson D, Schober DA, Starbäck P, Gehlert DR, Larhammar D (1996) The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous human receptor. Proc Natl Acad Sci USA 93: 5111-5115
64. Maisel AS, Scott NA, Motulsky HJ, Michel MC, Boublik JH, Rivier JE, Ziegler M, Allen RS, Brown MR (1989) Elevation of plasma neuropeptide Y levels in congestive heart failure. Am J Med 86: 43-48
65. Malik KU, Nasjletti A (1979) Attenuation by bradykinin of adrenergically-induced vasoconstriction in the isolated perfused kidney of the rabbit: relationship to prostaglandin synthesis. Br J Pharmacol 67: 269-274
66. 1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 354: 633-642
67. 1 receptor mediated sympathetic vasoconstriction in pigs in vivo. Eur J Pharmacol 305: 145-154
68. Martin JR, Knuepfer MM, Beinfeld MC, Westfall TC (1989) Mechanism of pressor response to posterior hypothalamic injection of neuropeptide Y. Am J Physiol 257: H791-H798
69. Matsumoto M, Nomura T, Momose K, Ikeda Y, Kondou Y, Akiho H, Togami J, Kimura Y, Okada M, Yamaguchi T (1996) Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J Biol Chem 271: 27217-27220
70. McDermott BJ, Millar BC, Piper HM (1993) Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms. Cardiovasc Res 27: 893-905
71. Mentlein R, Dahms P, Grandt D, Krüger R (1993) Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 49: 133-144
72. Michel MC, Gaida W, Beck-Sickinger AG, Wieland HA, Doods H, Dürr H, Jung G, Schnorrenberg G (1992) Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: Evidence for subtype-differentiating effects on affinity and intrinsic efficacy. Mol Pharmacol 42: 642-648
73. Michel MC, Rascher W (1995) Neuropeptide Y - a possible role in hypertension? J Hypertension 13: 385-395
74. Michel MC, Beck-Sickinger AG, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwatz TW, Westfall TC (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY and pancreatic polypeptide receptors. Pharmacol Rev (in press)
75. Minson R, McRitchie R, Chalmers J (1989) Effects of neuropeptide Y on the renal, mesenteric and hindlimb vascular beds of the conscious rabbit. J Auton Nerv System 27: 139-146
76. Minson RB, McRitchie RJ, Morris MJ, Chalmers JP (1990) Effects of neuropeptide Y on cardiac performance and renal blood flow in conscious normotensive and renal hypertensive rabbits. Clin Exptl Hypert A12: 267-284
77. Modin A, Pernow J, Lundberg JM (1991) Evidence for two neuropeptide Y receptors mediating vasoconstriction. Eur J Pharmacol 203: 165-171
78. Modin A, Pernow J, Lundberg JM (1994) Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine. J Auton Nerv System 49: 123-134
79. Modin A, Pernow J, Lundberg JM (1996) Prejunctional regulation of reserpine-resistant sympathetic vasoconstriction and release of neuropeptide Y in the pig. J Auton Nerv System 57: 13-21
80. Nakamura M, Sakanaka C, Aoki Y, Ogasawara H, Tsuji T, Kodama H, Matsumoto T, Shimizu T, Noma M (1995) Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and function expression of the receptors. J Biol Chem 270: 30102-30110
81. Nobiling R, Gabel M, Persson PB, Dietrich MS, Bührle CP (1991) Differential effect of neuropeptide-Y on membrane potential of cells in renal arterioles of the hydronephrotic mouse. J Physiol (Lond) 444: 317-327
82. Norvell JE, MacBride RG (1989) Neuropeptide Y (NPY)-like immunoactive nerve fibers in the human and monkey (Macaca fascicularis) kidney. Neurosci Lett 105: 63-67
83. Oellerich WF, Malik KU (1993) Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney. J Pharmacol Exp Ther 266: 1321-1329
84. +-ATPase activity in synergism with neuropeptide Y. Diabetologia 39: 199-205
85. +-ATPase activity. Kidney Int 45: 1606-1613
86. +-ATPase. Pediatr Res 39: 534-538
87. Owen MP (1993) Similarities and differences in the postjunctional role for neuropeptide Y in sympathetic vasomotor control of large vs. small arteries of rabbit renal and ear vasculature. J Pharmacol Exp Ther 265: 887-895
88. Pavia JM, Morris MJ (1994) Age-related changes in neuropeptide Y content in brain and peripheral tissues of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 21: 335-338
89. Pernow J, Lundberg JM (1989) Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig. Acta Physiol Scand 136:507-517
90. 2, NPY and angiotensin II receptors. Naunyn-Schmiedeberg's Arch Pharmacol 340: 379-385
91. Persson PB, Ehmke H, Nafz B, Lang R, Hackenthal E, Nobiling R, Dietrich MS, Kirchheim HR (1991) Effects of neuropeptide-Y on renal function and its interaction with sympathetic stimulation in conscious dogs. J Physiol (Lond) 444: 289-302
92. Pfister A, Waeber B, Nussberger J, Brunner HR (1986) Neuropeptide Y normalizes renin secretion in adrenalectomized rats without changing blood pressure. Life Sci 39: 2161-2167
93. Pham I, Gonzalez W, Doucet J, Fournier-Zaluski M-C, Roques BP, Michel J-B (1996) Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin. Eur J Pharmacol 296: 267-276
94. Pironi L, Stanghellini V, Miglioli M, Corinaldesi R, De Giorgio R, Ruggeri E, Tosetti C, Poggioli G, Labate AMM, Monetti N, Gozzetti G, Barbara L, Go VLW (1993) Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology 105: 733-739
95. Playford JR, Mehta S, Upton P, Rentch R, Moss S, Calam J, Bloom S, Payne N, Ghatei M, Edwards R, Unwin R (1995) Effect of peptide YY on human renal function. Am J Physiol 268: F754-F759
96. Price JS, Kenny AJ, Huskisson NS, Brown MJ (1991) Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney. Br J Pharmacol 104: 321-326
97. Regoli D, Barabe J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32: 1-36
98. Reinecke M, Forssmann WG (1988) Neuropeptide (neuropeptide Y, neurotensin, vasoactive intestinal polypeptide, substance P, calcitonin gene-related peptide, somatostatin) immunohistochemistry and ultrastructure of renal nerves. Histochemistry 89: 1-9
99. Rump LC, Riess M, Schwertfeger E, Michel MC, Bohmann C, Schollmeyer P (1997) Prejunctional neuropeptide Y receptors in human kidney and atrium. J Cardiovasc Pharmacol 29: 656-661
100. Schachter M, Miles CMM, Leys K, Sever PS (1987) Characterization of neuropeptide Y receptors in rabbit kidney: preliminary comparisons with rat and human kidney. J Cardiovasc Pharmacol 10 (Suppl 12) S157-S162
101. Schuster VL, Kokko JP, Jacobson HR (1984) Interactions of lysyl-bradykinin and antidiuretic hormone in the rabbit cortical collecting tubule. J Clin Invest 73: 1659-1667
102. Reference deleted
103. 2-type receptors for peptide YY on renal proximal tubular cells in the rabbit. Am J Physiol 257: F978-F984
104. Siragy HM (1993) Evidence that intrarenal bradykinin plays a role in regulation of renal function. Am J Physiol 265: E648-E654
105. Smyth DD, Blandford DE, Thom SL (1988) Disparate effects of neuropeptide Y and clonidine on the excretion of sodium and water in the rat. Eur J Pharmacol 152: 157-162
106. i2 proteins in renal proximal tubule cells. J Biol Chem 271: 574-580
107. Waeber B, Evequoz D, Aubert J-F, Flückiger J-P, Juillerat L, Nussberger J, Brunner HR (1990) Prevention of renal hypertension in the rat by neuropeptide Y. J Hypertension 8: 21-25
108. Wharton J, Gordon L, Byrne J, Herzog H, Selbie LA, Moore K, Sullivan MHF, Elder MG, Moscoso G, Taylor KM, Shine J, Polak JM (1993) Expression of the human neuropeptide tyrosine Y1 receptor. Proc Natl Acad Sci USA 90: 687-691
109. Wieland HA, Willim K, Doods HN (1995) Receptor binding profiles of NPY analogues and fragments in different tissues and cell lines. Peptides 16: 1389-1394
110. Yan H, Yang J, Marasco J, Yamaguchi K, Brenner S, Collins F, Karbon W (1996) Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors. Proc Natl Acad Sci USA 93: 4661-4665
111. Zelis R, Nussberger J, Clemson B, Waeber B, Grouzmann E, Brunner HR (1994) Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats. J Cardiovasc Pharmacol 24: 896-899
112. Zukowska-Grojec Z, Wahlestedt C (1993) Origin and actions of neuropeptide Y in the cardiovascular system. In: Colmers WF, Wahlestedt C (eds) The biology of neuropeptide Y and related peptides. Humana Press, Totowa, 315-388